Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01472835 · ClinicalTrials.gov registry record · NA
Effect of Sedation on Diagnostic Injections
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT01472835: Completed NA study, sponsored by Johns Hopkins University.
NCT01472835 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01472835, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
Interventional pain procedures have diagnostic, prognostic and therapeutic value. It is well-documented that the reference standard for identifying a pain generator is a low-volume block performed with local anesthetic, with or without steroid. Many factors may increase the false positive (FP) rate of diagnostic and prognostic nerve blocks; however, the use of sedation is the most controversial and remediable. Proponents of sedation argue that it has little effect on the rate of positive diagnostic blocks, and may even reduce the false-negative rate. The purpose of this study is to determine the effect of intravenous sedation on pain relief and the "false-positive rate" after diagnostic nerve blocks.
Interventions
- DRUG Midazolam
- DRUG Fentanyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2011-03 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01472835
The ClinicalTrials.gov registry entry for NCT01472835 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midazolam is the first listed.
NCT01472835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01472835 about?
NCT01472835 is a clinical study titled "Effect of Sedation on Diagnostic Injections". Interventional pain procedures have diagnostic, prognostic and therapeutic value. It is well-documented that the reference standard for identifying a pain generator is a low-volume block performed with local anesthetic, with or without steroid. Many factors may increase the false positive (FP) rate ...
What is the current status of trial NCT01472835?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2011-03. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01472835?
The interventions under investigation include: Midazolam (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT01472835?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.